Ledger.Open graph →
SEC Form D · filed November 12, 2015

Amplyx Pharmaceuticals, Inc

Offering
$47.0M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Ed Mathers · SAN DIEGO, CADirectorMitchell Mutz · SAN DIEGO, CAExecMichael Grey · SAN DIEGO, CAExec · DirectorElaine Heron · SAN DIEGO, CADirectorNiall Odonnell · SAN DIEGO, CADirectorCiara Kennedy · SAN DIEGO, CAExecCaroline Popper · Rockville, MDExecRowan Chapman · San Mateo, CAExec · DirectorRaj Ganguly · San Mateo, CAExecDeborah Kilpatrick · San Mateo, CADirectorMax Mcdermott · Tustin, CADirectorRubina N. Toorawa · Ebene, O4DirectorKaran Rai · ASHEVILLE, NCDirectorJulianne Y. Ramming · New York, NYExecLin-Lin Zhou · Shanghai, IsraelDirectorJames Ahn · Shanghai, IsraelDirectorChristopher T. Demetriou · Philadelphia, PAExecAllan M. Bernheimer · Trumbull, CTExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗